Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions
2024-07-16
(Press-News.org)
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths. The primary curative treatments for HCC are liver transplantation, hepatectomy, and local ablation. However, the recurrence rate of HCC following hepatectomy or ablation remains alarmingly high, up to 70%, severely impacting patient prognosis and overall survival (OS). To mitigate postoperative recurrence and improve patient outcomes, various adjuvant therapies have been explored. Despite the efficacy of several adjuvant treatments in reducing recurrence rates and enhancing survival, there is no standardized consensus on their application across national guidelines, leading to significant disparities in recommendations between Eastern and Western medical practices.
HCC recurrence can generally be classified into two categories: early recurrence, which typically occurs within two years post-treatment, and late recurrence, which occurs after two years. Early recurrence is often linked to intrahepatic micrometastases or microthrombi from the primary tumor, whereas late recurrence is usually associated with multicentric new tumor formations. Risk factors for early recurrence include large tumor size (>5 cm), multiple tumors, the presence of satellite lesions, lack of a tumor capsule, tumor rupture, non-anatomical resection, narrow resection margins (≤2 cm), high alpha-fetoprotein levels (≥400 ng/mL), and microvascular or macrovascular invasion. Conversely, late-recurrence risk factors include liver cirrhosis, higher hepatitis activity grades, and poor tumor classification.
The primary aim of adjuvant therapy following local treatments like hepatectomy or ablation is to reduce the recurrence rate and thus improve recurrence-free survival (RFS) and OS. The choice of adjuvant therapy should be guided by the risk factors specific to early or late recurrence.
Antiviral Therapy: For patients with hepatitis-related HCC, antiviral therapy aims to inhibit long-term viral replication, reduce liver damage, prevent disease progression, and ultimately prolong survival. For HCV-related HCC, sustained viral eradication using interferon-based or interferon-free regimens significantly reduces recurrence. Similarly, for HBV-related HCC, nucleos(t)ide analogs such as tenofovir and entecavir are recommended. Studies have shown that tenofovir is particularly effective in reducing recurrence and improving survival compared to entecavir.
Transarterial Chemoembolization (TACE): This is often used as an adjuvant therapy for patients at high risk of intrahepatic metastasis. TACE targets disseminated tumor cells that have spread from the primary tumor, helping to reduce early recurrence by effectively eliminating residual tumors.
Immune Checkpoint Inhibitors (ICIs): Recent guidelines, particularly in the United States, have begun to include recommendations for ICIs in the adjuvant setting. ICIs help boost the body's antitumor immunity and have shown promise in reducing recurrence rates and improving survival outcomes in HCC patients.
Despite the promising results of various adjuvant therapies, there remain several unanswered questions and challenges. The lack of a universally accepted standard for adjuvant therapy in HCC highlights the need for further research and clinical trials to establish clear guidelines. Moreover, the balance between the benefits and potential adverse effects of adjuvant treatments must be carefully considered to optimize patient outcomes. Future studies should aim to refine patient selection criteria for adjuvant therapies, tailoring treatments based on individual risk profiles to maximize efficacy and minimize harm.
In conclusion, while significant strides have been made in the development of adjuvant therapies for HCC, ongoing research and international collaboration are essential to standardize treatment protocols and improve the prognosis for HCC patients worldwide.
Full text
https://www.xiahepublishing.com/2310-8819/JCTH-2024-00030
The study was recently published in the Journal of Clinical and Translational Hepatology.
The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-07-16
INDIANAPOLIS – Palliative care, specialized medical care focusing on providing relief from the symptoms -- including pain -- and the stress of serious illness, is underutilized in nursing homes, despite the large number of nursing home residents living with a serious illness such as cancer, dementia, Parkinson’s disease, heart failure or chronic obstructive pulmonary disease.
A qualitative study, published in the Journal of the American Geriatrics Society, analyzes lack of palliative ...
2024-07-16
Milan, July 15, 2024 – By the age of three, children are capable of understanding others, "mirroring" those they are with to imitate and anticipate their intentions. They are able to do it thanks to the sophisticated neurofunctional architecture that is necessary to understand others' intentions, the mirror neurons, that result already active at this age.
It’s the result of a study published in the prestigious journal PNAS, led by the collaboration between Giacomo Rizzolatti of the University of ...
2024-07-16
EMBARGO: THIS CONTENT IS UNDER EMBARGO UNTIL 9 A.M. U.S. EASTERN STANDARD TIME ON JULY 16. INTERESTED MEDIA MAY RECIVE A PREVIEW COPY OF THE JOURNAL ARTICLE IN ADVANCE OF THAT DATE OR CONDUCT INTERVIEWS, BUT THE INFORMATION MAY NOT BE PUBLISHED, BROADCAST, OR POSTED ONLINE UNTIL AFTER THE RELEASE WINDOW.
New research shows that ozone concentrations at Carlsbad Caverns National Park frequently exceed Environmental Protection Agency health standards, likely due to oil and natural gas development in the Permian Basin and surrounding region.
The work was led through the Department of Atmospheric Science at Colorado State University and is part of ...
2024-07-16
ITHACA, N.Y. – Researchers studying antimicrobial-resistant E. coli – the leading cause of human death due to antimicrobial resistance worldwide – have identified a mechanism in dogs that may render multiple antibiotic classes ineffective.
The paper, which will publish July 16 in the journal Applied and Environmental Microbiology at 9:00am EST, opens up new avenues for therapies to treat both animals and humans – and establishes clinical infections in dogs as a surveillance approach for public health.
The research team analyzed more than 1,000 genomes of the resistant ...
2024-07-16
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective management and improved survival rates. Ultrasound (US) technology has significantly advanced and plays a pivotal role in the surveillance, diagnosis, and treatment of HCC. This paper delves into various ultrasound techniques and their clinical applications in HCC management.
Two-dimensional gray-scale ultrasound is a fundamental imaging technique for HCC surveillance. ...
2024-07-16
Democrats and Republicans overestimate the percentage of people in the opposing party who approve of widely agreed-upon moral wrongs, such as theft or animal abuse, according to a study. Today, Americans hate their opposing political party more than they love their own party, and political animosity and dehumanization of opposing party members have been on the rise for decades. Curtis Puryear and colleagues looked for a “basic morality bias” in social media posts from 5,806 political partisans by searching for words that referencd ...
2024-07-16
Mohammad Atari and colleagues explore the promise and peril of using large language models (LLMs) in psychological research, beginning by urging researchers to also ask themselves whether and why they should use LLMs—not just how they should use them. The authors caution against using LLMs as a replacement for human participants, noting that LLMs cannot capture the substantial cross-cultural variation in cognition and moral judgement known to exist. Most LLMs have been trained on data primarily from WEIRD (Western, Educated, Industrialized, Rich, Democratic) sources, disproportionately in English. Additionally, although ...
2024-07-16
Large language models (LMs) can complete abstract reasoning tasks, but they are susceptible to many of the same types of mistakes made by humans. Andrew Lampinen, Ishita Dasgupta, and colleagues tested state-of-the-art LMs and humans on three kinds of reasoning tasks: natural language inference, judging the logical validity of syllogisms, and the Wason selection task. The authors found the LMs to be prone to similar content effects as humans. Both humans and LMs are more likely to mistakenly label an invalid argument as valid when the semantic content is sensical and believable. LMs are also just as bad as humans at the Wason selection task, in which the participant ...
2024-07-16
A study combining history, economics, and fluvial geomorphology examines the causes of the adoption of coal power during the Industrial Revolution in Great Britain. At the beginning of the mechanization of the textile industry in Britain, most machines were powered with waterpower. Eventually waterpower was replaced by using coal to make steam power and the causes of this shift have long been debated. One influential hypothesis has been that waterpower became scarce in the industrial heartland of northwest England during the early 19th century, as all available suitable sites were already fitted with ...
2024-07-16
Industrial emissions are one of the main sources of climate change-inducing carbon dioxide (CO2). While adopting renewable and clean energy alternatives is one option for mitigating these carbon emissions, carbon capture technology is another solution to control CO2 emissions. In big CO2-emitting industries, such as cement, oil refineries, and thermal power plants, carbon capture technology can be easily applied to remove CO2 emissions directly at the source at a feasible cost and with low energy consumption. Different materials have been explored for CO2 capture in factories, including zeolites, metal−organic frameworks, natural minerals, alkalis, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions
